文献速递儿童血液肿瘤与免疫儿童神经与发育行为

儿童急性淋巴细胞白血病合并脑静脉血栓形成14例分析

[Acute lymphoblastic leukemia complicated with cerebral venous thrombosis in 14 children].
PubMed 文献 · Zhonghua Er Ke Za Zhi · 2020-01-01

回顾性分析14例ALL合并CVT患儿,CVT发生率为2.8%(14/505),中位发病年龄10(3~14)岁,11例发生在诱导缓解阶段,主要表现为抽搐、意识障碍及头痛。抗凝治疗以低分子肝素联合或序贯华法林为主,再次使用门冬酰胺酶无CVT复发或加重,预后良好。

要点

  • ALL诱导缓解期继发性凝血功能紊乱是CVT主要风险,需积极监测和早期预防。
  • CVT急性期常见抽搐(9例)、意识障碍(6例)和头痛(4例)。
  • 动静脉造影可准确诊断,低分子肝素联合华法林抗凝治疗预后良好。

核心结论

  • ALL诱导缓解治疗中继发性凝血功能紊乱是合并CVT的主要因素,需积极监测和早期预防。
  • 动静脉造影可准确诊断CVT,低分子肝素和华法林抗凝治疗预后良好。

研究设计与样本

  • 回顾性分析2011年1月至2019年10月中山大学孙逸仙纪念医院儿科收治的14例ALL合并CVT患儿的临床资料。
  • 分析内容包括临床表现、凝血功能、影像学特点、治疗方案及预后。

主要发现

  • CVT发生率为2.8%(14/505),中位发病年龄10(3~14)岁,11例发生在诱导缓解阶段。
  • 急性期表现为抽搐9例、意识障碍6例、头痛4例。
  • 8例CVT前抗凝血酶Ⅲ活性低于60%,8例症状当天D二聚体升高。
  • 动静脉造影示单部位静脉窦充盈缺损9例、多部位5例,最常见上矢状窦10例,继发颅内出血5例。
  • 再次使用门冬酰胺酶未发现CVT复发或加重。

关键数值与推荐

  • 抗凝治疗:低分子肝素联合华法林9例,序贯使用低分子肝素和华法林2例,单用低分子肝素3例。

临床怎么用

  • 对ALL诱导缓解期患儿应积极监测凝血功能,警惕CVT发生。
  • 出现抽搐、意识障碍或头痛时,应考虑CVT并行动静脉造影明确诊断。
  • 确诊CVT后可采用低分子肝素联合或序贯华法林抗凝治疗。

局限性

  • 本研究为单中心回顾性分析,样本量小(14例),结论需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To explore the clinical characteristics and management of childhood acute lymphoblastic leukemia (ALL) complicated with cerebral venous thrombosis (CVT). Methods: The clinical data of 14 ALL children complicated with CVT who were admitted to Department of Pediatrics of Sun Yat-sen Memorial Hospital and underwent chemotherapy from January 2011 to October 2019 were collected retrospectively. The clinical manifestations, coagulation function, imaging findings, treatment plan and prognosis of patients were analyzed. Results: CVT was diagnosed in 14 (2.8%, 14/505) cases, with a median age of 10 (3-14) years at onset, 11 cases occurred in the stage of induction remission, and the acute onsets were mainly characterized by convulsions (9 cases), consciousness disorders (6 cases) and headache (4 cases). Coagulation function test showed that, before the CVT, antithrombin Ⅲ activity was lower than 60% in 8 cases, D-dimer elevated on the day of onset in 8 cases. Arteriovenous angiography showed filling defects in single (9 cases) or multiple (5 cases) venous sinuses. The most common site of venous sinus enlargement was superior sagittal sinus (10 cases). Secondary cerebral hemorrhage was found in 5 cases. Anticoagulation therapy included combination of low-molecular-weight heparin (LMWH) and warfarin in 9 cases, sequential application of LMWH and warfarin in 2 cases, and LMWH alone in 3 cases. Patients accepted further asparaginase and no CVT recurrence or progression was found. Conclusions: The secondary coagulation dysfunction during induction remission chemotherapy is the major risk factor for CVT in ALL, which needs active monitoring and early prevention. Arteriovenous angiography can diagnose accurately, and the prognosis of anticoagulant therapy with LMWH and warfarin is optimistic. 目的: 探讨儿童急性淋巴细胞白血病(ALL)合并脑静脉血栓形成(CVT)的临床特点及诊疗对策。 方法: 纳入2011年1月至2019年10月在中山大学孙逸仙纪念医院儿科住院并接受化疗的ALL合并CVT的14例患儿的临床资料进行回顾性分析,分析其临床表现、凝血功能、影像学特点、治疗方案。 结果: CVT发生率为2.8%(14/505)。14例患儿男11例、女3例,CVT发病年龄10(3~14)岁。11例发生在诱导缓解阶段,急性期表现为抽搐(9例)、意识障碍(6例)及头痛(4例)。凝血功能检测发现,8例发生CVT前抗凝血酶Ⅲ活性低于60%,8例出现症状当天D二聚体升高。动静脉造影示单部位(9例)或多部位(5例)静脉窦内充盈缺损,静脉窦增宽,最常见部位为上矢状窦(10例),5例继发颅内出血。抗凝治疗包括联合及序贯使用低分子肝素(LMWH)和华法林,分别为9例和2例,单用LMWH3例,再次使用门冬酰胺酶无CVT反复或加重。 结论: ALL诱导缓解治疗中继发性凝血功能紊乱是合并CVT主要因素,需积极监测、早期预防,动静脉造影可准确诊断,LMWH和华法林抗凝治疗预后良好。.

来源:Zhonghua Er Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Liu TH, Li XY, Han XW, et al. [Acute lymphoblastic leukemia complicated with cerebral venous thrombosis in 14 children]. Zhonghua Er Ke Za Zhi. 2020. PMID: 32872718. doi:10.3760/cma.j.cn112140-20200203-00058

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。